Ernexa Therapeutics Inc.
13F holders, Q1 2024 (March 31)23holders
2famous investors
$2.40avg. 13F price*
At the end of Q1 2024, 23 institutions reported holding Ernexa Therapeutics Inc. in their 13F filings. The largest holders were Cypress Point Wealth Management, LLC ($227K), Naviter Wealth, LLC ($189K) and Sippican Capital Advisors ($175K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Ernexa Therapeutics Inc.
- Filed as
- ETERNA THERAPEUTICS INC (Q1 2024)
- CUSIP
- 114082209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $86K |
| Exits | 2 | $29 |
Ownership 23 holders
| Cypress Point Wealth Management, LLC | 0.12% | No change | 94,375 | $227K |
| Naviter Wealth, LLC | 0.03% | No change | 78,796 | $189K |
| Sippican Capital Advisors | 0.14% | Add +34.7% | 72,800 | $175K |
| Corient Private Wealth LP | 0.00% | No change | 50,398 | $120K |
| Vanguard Group Inc. | 0.00% | No change | 26,099 | $63K |
| Geode Capital Management, LLC | 0.00% | No change | 22,488 | $54K |
| BlackRock Inc. | 0.00% | No change | 15,619 | $37K |
| Avidian Wealth Enterprises, LLC | 0.00% | New | 14,798 | $36K |
| Citadel Advisors | 0.00% | New | 10,091 | $24K |
| Renaissance Technologies | 0.00% | New | 10,083 | $24K |
| Baldwin Wealth Partners LLC | 0.00% | No change | 8,544 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -7.4% | 4,083 | $10K |
| UBS Group AG | 0.00% | New | 741 | $2K |
| Lanark Financial, Inc. | 0.00% | New | 10 | $1K |
| Montag A & Associates Inc. | 0.00% | Add +101.4% | 141 | $339 |
| Morgan Stanley | 0.00% | No change | 50 | $120 |
| Wells Fargo & Company | 0.00% | No change | 28 | $67 |
| Group One Trading LLC | 0.00% | No change | 19 | $45 |
| Citigroup Inc. | 0.00% | No change | 15 | $36 |
| JPMorgan Chase & Co. | 0.00% | No change | 14 | $33 |
| Aspire Private Capital, LLC | 0.00% | No change | 10 | $24 |
| Qube Research & Technologies Ltd | 0.00% | No change | 4 | $10 |
| Royal Bank of Canada | 0.00% | Reduce -29.0% | 22 | $0 |
"% of holder's portfolio" is ERNEXA THERAPEUTICS INC's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. the manager owns.